Transcriptome and proteome analyses reveal that upregulation of GSTM2 by allisartan improves cardiac remodeling and dysfunction in hypertensive rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcriptome and proteome analyses reveal that upregulation of GSTM2 by allisartan improves cardiac remodeling and dysfunction in hypertensive rats

Published:2024-03-21 Issue:5 Volume:27 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wu Hao¹,Zhai Yajun²,Yu Jing³,Wei Liping⁴,Qi Xin⁴

Affiliation:

1. School of Medicine, Nankai University, Tianjin 300071, P.R. China

2. Graduate School, Tianjin Medical University, Tianjin 300070, P.R. China

3. Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin 300070, P.R. China

4. School of Medicine, Nankai University, Tianjin 300071, P.R. China

Publisher

Spandidos Publications

Reference56 articles.

1. Trends in prevalence and control of hypertension according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline;Dorans;J Am Heart Assoc,2018

2. Endogenous CCN5 Participates in Angiotensin II/TGF-β1 networking of cardiac fibrosis in high angiotensin II-induced hypertensive heart failure;Huang;Front Pharmacol,2020

3. Modulation of EndMT by hydrogen sulfide in the prevention of cardiovascular fibrosis;Testai;Antioxidants (Basel),2021

4. Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage;Ling;Acta Pharmacol Sin,2021

5. Carboxylesterase 2 and intestine transporters contribute to the low bioavailability of Allisartan, a Prodrug of Exp3174 for hypertension treatment in humans;Li;Drug Metab Dispos,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of Allisartan Isoproxil in patients with hypertension: a meta-analysis;Frontiers in Cardiovascular Medicine;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3